Medtronic plc (MDT) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-03 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Medtronic plc (MDT) CIK: 0001613103 --- Reporting Owner --- Name: Pieton Thierry CIK: 0002056622 Role: Officer (EVP & Chief Financial Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Ordinary Shares Date: 2026-08-03 | Code: A (Grant or award) Shares: +11,537 | Price: $0.00 Shares Owned After: 49,645 | Ownership: D (Direct) Footnotes: [F1] Represents restricted stock units that vest 100% on the third anniversary of the date of grant. [F2] Includes 534 shares acquired through dividend reinvestment since the last report filed by the reporting person. --- Derivative Transactions --- [Transaction #1] Security: Performance Share Units Date: 2026-08-03 | Code: A (Grant or award) Shares: +28,842 | Price: $0.00 Shares Owned After: 28,842 | Ownership: D (Direct) Footnotes: [F3] Each performance share unit represents a contingent right to receive one share of Medtronic common stock. [F4] Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029. [F4] Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029. [F5] The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 28,842 shares will be issued. If maximum performance metrics are achieved, 69,221 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. [Transaction #2] Security: Stock Option (Right to Buy) Date: 2026-08-03 | Code: A (Grant or award) Shares: +81,945 | Price: $0.00 Exercisable: N/A | Expires: 2036-08-03 Shares Owned After: 81,945 | Ownership: D (Direct) Footnotes: [F6] These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. --- Footnotes (Complete Index) --- F1: Represents restricted stock units that vest 100% on the third anniversary of the date of grant. F2: Includes 534 shares acquired through dividend reinvestment since the last report filed by the reporting person. F3: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4: Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029. F5: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 28,842 shares will be issued. If maximum performance metrics are achieved, 69,221 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F6: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. --- Signature --- /s/ /s/ Patricia Walesiewicz, attorney-in-fact (2026-08-04)